Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001408502-25-000007
Filing Date
2025-10-14
Accepted
2025-10-14 16:19:02
Documents
2
Period of Report
2025-10-13

Document Format Files

Seq Description Document Type Size
1 form3-10142025_081058.html 3  
1 form3-10142025_081058.xml 3 1703
2 ex24-10142025_081000.htm EX-24 9500
  Complete submission text file 0001408502-25-000007.txt   12706
Mailing Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517
Business Address
Hahn Mark W (Reporting) CIK: 0001408502 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36593 | Film No.: 251391988

Mailing Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065
Business Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Issuer) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)